PROVIDER PROFILE · NPI 1063446532

Mark Munekata

General PracticeTorrance, CAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

144

Beneficiaries

—

Total drug cost

$1K

Distinct drugs

Brand share

0.0%

Top prescribed drugs

Atorvastatin Calcium32 claims

Lisinopril23 claims

Amlodipine Besylate22 claims

Metformin Hcl17 claims

Fluticasone Propionate14 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 050376

Hospital

REFERRAL NETWORK

Where Mark Munekata's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 1 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
COUNTY OF LOS ANGELES	30	62

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
COUNTY OF LOS ANGELES	77	176

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history